Literature DB >> 24095252

Automated procedure for biomimetic de-cellularized lung scaffold supporting alveolar epithelial transdifferentiation.

Eric D Girard1, Todd J Jensen, Stephanie D Vadasz, Alex E Blanchette, Fan Zhang, Camilo Moncada, Daniel J Weiss, Christine M Finck.   

Abstract

The optimal method for creating a de-cellularized lung scaffold that is devoid of cells and cell debris, immunologically inert, and retains necessary extracellular matrix (ECM) has yet to be identified. Herein, we compare automated detergent-based de-cellularization approaches utilizing either constant pressure (CP) or constant flow (CF), to previously published protocols utilizing manual pressure (MP) to instill and rinse out the de-cellularization agents. De-cellularized lungs resulting from each method were evaluated for presence of remaining ECM proteins and immunostimulatory material such as nucleic acids and intracellular material. Our results demonstrate that the CP and MP approaches more effectively remove cellular materials but differentially retain ECM proteins. The CP method has the added benefit of being a faster, reproducible de-cellularization process. To assess the functional ability of the de-cellularized scaffolds to maintain epithelial cells, intra-tracheal inoculation with GFP expressing C10 alveolar epithelial cells (AEC) was performed. Notably, the CP de-cellularized lungs were able to support growth and spontaneous differentiation of C10-GFP cells from a type II-like phenotype to a type I-like phenotype.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alveolar epithelial cell; C10 alveolar cells; De-cellularization; Extracellular matrix; Lung; Scaffold

Mesh:

Year:  2013        PMID: 24095252      PMCID: PMC4017665          DOI: 10.1016/j.biomaterials.2013.09.055

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  37 in total

1.  Modulation of pulmonary alveolar type II cell phenotype and communication by extracellular matrix and KGF.

Authors:  B E Isakson; R L Lubman; G J Seedorf; S Boitano
Journal:  Am J Physiol Cell Physiol       Date:  2001-10       Impact factor: 4.249

Review 2.  Alveolar type I cells: molecular phenotype and development.

Authors:  Mary C Williams
Journal:  Annu Rev Physiol       Date:  2002-05-01       Impact factor: 19.318

Review 3.  Influence of the extracellular matrix on type 2 cell differentiation.

Authors:  D E Rannels; S R Rannels
Journal:  Chest       Date:  1989-07       Impact factor: 9.410

4.  Transformation of alveolar type 2 cells to type 1 cells following exposure to NO2.

Authors:  M J Evans; L J Cabral; R J Stephens; G Freeman
Journal:  Exp Mol Pathol       Date:  1975-02       Impact factor: 3.362

5.  Effect of a reconstituted basement membrane on expression of surfactant apoproteins in cultured adult rat alveolar type II cells.

Authors:  J M Shannon; P A Emrie; J H Fisher; Y Kuroki; S D Jennings; R J Mason
Journal:  Am J Respir Cell Mol Biol       Date:  1990-02       Impact factor: 6.914

Review 6.  Expanding the frontiers of lung biology through the creative use of alveolar epithelial cells in culture.

Authors:  R Paine; R H Simon
Journal:  Am J Physiol       Date:  1996-04

7.  Culture of type II pneumocytes on a type II cell-derived fibronectin-rich matrix.

Authors:  S R Rannels; C S Fisher; L J Heuser; D E Rannels
Journal:  Am J Physiol       Date:  1987-12

8.  Dynamic reciprocity: how do extracellular matrix and hormones direct gene expression?

Authors:  M J Bissell; J Aggeler
Journal:  Prog Clin Biol Res       Date:  1987

9.  Repopulation of a human alveolar matrix by adult rat type II pneumocytes in vitro. A novel system for type II pneumocyte culture.

Authors:  J S Lwebuga-Mukasa; D H Ingbar; J A Madri
Journal:  Exp Cell Res       Date:  1986-02       Impact factor: 3.905

10.  Bleomycin-induced injury and metaplasia of alveolar type 2 cells. Relationship of cellular responses to drug presence in the lung.

Authors:  I Y Adamson; D H Bowden
Journal:  Am J Pathol       Date:  1979-08       Impact factor: 4.307

View more
  6 in total

1.  An official American Thoracic Society workshop report: stem cells and cell therapies in lung biology and diseases.

Authors:  Daniel J Weiss; Daniel Chambers; Adam Giangreco; Armand Keating; Darrell Kotton; Peter I Lelkes; Darcy E Wagner; Darwin J Prockop
Journal:  Ann Am Thorac Soc       Date:  2015-04

2.  Enhanced reseeding of decellularized rodent lungs with mouse embryonic stem cells.

Authors:  Shimon Lecht; Collin T Stabler; Alexis L Rylander; Rachel Chiaverelli; Edward S Schulman; Cezary Marcinkiewicz; Peter I Lelkes
Journal:  Biomaterials       Date:  2014-01-15       Impact factor: 12.479

3.  Enhanced Re-Endothelialization of Decellularized Rat Lungs.

Authors:  Collin T Stabler; Luiz C Caires; Mark J Mondrinos; Cezary Marcinkiewicz; Philip Lazarovici; Marla R Wolfson; Peter I Lelkes
Journal:  Tissue Eng Part C Methods       Date:  2016-04-01       Impact factor: 3.056

4.  Recellularization of decellularized lung scaffolds is enhanced by dynamic suspension culture.

Authors:  Aurélie Crabbé; Yulong Liu; Shameema F Sarker; Nicholas R Bonenfant; Jennifer Barrila; Zachary D Borg; James J Lee; Daniel J Weiss; Cheryl A Nickerson
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

Review 5.  3D Bioprinting Strategies, Challenges, and Opportunities to Model the Lung Tissue Microenvironment and Its Function.

Authors:  Mabel Barreiro Carpio; Mohammadhossein Dabaghi; Julia Ungureanu; Martin R Kolb; Jeremy A Hirota; Jose Manuel Moran-Mirabal
Journal:  Front Bioeng Biotechnol       Date:  2021-11-24

6.  Equine lung decellularization: a potential approach for in vitro modeling the role of the extracellular matrix in asthma.

Authors:  Renata Kelly da Palma; Paula Fratini; Gustavo Sá Schiavo Matias; Andressa Daronco Cereta; Leticia Lopes Guimarães; Adriana Raquel de Almeida Anunciação; Luis Vicente Franco de Oliveira; Ramon Farre; Maria Angelica Miglino
Journal:  J Tissue Eng       Date:  2018-11-12       Impact factor: 7.813

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.